Abstract:The Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)/Cas9 system, a groundbreaking innovation in genetic engineering, has revolutionized our approach to surmounting complex diseases, culminating in CASGEVY™ approved for sickle cell anemia. Derived from a microbial immune defense mechanism, CRISPR/Cas9, characterized as precision, maneuverability and universality in gene editing, has been harnessed as a versatile tool for precisely manipulating DNA in mammals. In the process of applying it to practice, the consecutive exploitation of novel orthologs and variants never ceases. It's conducive to understanding the essentialities of diseases, particularly cancer, which is crucial for diagnosis, prevention, and treatment. CRISPR/Cas9 is used not only to investigate tumorous genes functioning but also to model disparate cancers, providing valuable insights into tumor biology, resistance, and immune evasion. Upon cancer therapy, CRISPR/Cas9 is instrumental in developing individual and precise cancer therapies that can selectively activate or deactivate genes within tumor cells, aiming to cripple tumor growth and invasion and sensitize cancer cells to treatments. Furthermore, it facilitates the development of innovative treatments, enhancing the targeting efficiency of reprogrammed immune cells, exemplified by advancements in CAR-T regimen. Beyond therapy, it is a potent tool for screening susceptible genes, offering the possibility of intervening before the tumor initiative or progresses. However, despite its vast potential, the application of CRISPR/Cas9 in cancer research and therapy is accompanied by significant efficacy, efficiency, technical, and safety considerations. Escalating technology innovations are warranted to address these issues. The CRISPR/Cas9 system is revolutionizing cancer research and treatment, opening up new avenues for advancements in our understanding and management of cancers. The integration of this evolving technology into clinical practice promises a new era of precision oncology, with targeted, personalized, and potentially curative therapies for cancer patients.

CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research

Harnessing the evolving CRISPR/Cas9 for precision oncology

CRISPR Applications in Cancer Diagnosis and Treatment

A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment

Current applications and future perspective of CRISPR/Cas9 gene editing in cancer

CRISPR-Cas and CRISPR-based screening system for precise gene editing and targeted cancer therapy

Progress in the application of gene editing technology in cancer treatmentstaking CRISPR as an example

CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy

CRISPR-Cas9 for cancer therapy: Opportunities and challenges

CRISPR-Cas9: from Genome Editing to Cancer Research

Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy

Cancer Research Using Crispr/Cas9 Gene Editing Technology

Crispr/Cas9 Therapeutics: A Cure For Cancer And Other Genetic Diseases

Exposing Cancer with CRISPR-Cas9: from Genetic Identification to Clinical Therapy

CRISPR/Cas9 Technology: Challenges and drawbacks

Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics

CRISPR–Cas: a tool for cancer research and therapeutics

CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy

CRISPR/Cas Gene Editing and Delivery Systems for Cancer Therapy

Prospects and challenges of CRISPR/Cas9 gene‐editing technology in cancer research

CRISPR/Cas9 in cancer: An attempt to the present trends and future prospects